Acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solution — RxCUI 1919076
RxNorm drug concept · Semantic clinical drug
RxCUI 1919076
Semantic clinical drug · SCD
● Current RxNorm concept 11 FDA products
13 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1919076
Official nameAcetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 32.5 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML Oral Solution; acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution; acetaminophen 325 MG / dextromethorphan HBr 10 MG per 10 mL Oral Solution; acetaminophen 650 MG / dextromethorphan HBr 20 MG per 20 mL Oral Solution
FDA products mapped11
Package NDCs mapped13
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
- Why am I getting acetaminophen through an IV instead of just taking a pill?
- Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
- The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
🕸️ Concept Web — How Acetaminophen 32.5 MG/ML / dextromethorphan hydr... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solution
RxCUI 1919076 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Acetaminophen
161IN -
Dextromethorphan
3289IN -
Acetaminophen / dextromethorphan
214180MIN -
Dextromethorphan hydrobromide
102490PIN
-
Acetaminophen
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetaminophen / dextromethorphan Oral Solution
370756SCDF -
Acetaminophen / dextromethorphan hydrobromide Oral Solution
2647014SCDFP -
Acetaminophen / dextromethorphan Oral Liquid Product
1151183SCDG -
Acetaminophen / dextromethorphan Oral Product
1151184SCDG -
Acetaminophen / dextromethorphan hydrobromide Oral Liquid Product
2661513SCDGP -
Acetaminophen / dextromethorphan hydrobromide Oral Product
2662804SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Acetaminophen / dextromethorphan Oral Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetaminophen 32.5 MG/ML
336021SCDC -
Dextromethorphan hydrobromide 1 MG/ML
1020137SCDC
-
Acetaminophen 32.5 MG/ML
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{1 (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / triprolidine hydrochloride 0.125 MG/ML Oral Solution) / 1 (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solution) } Pack
GPCK · 2744509 -
Acetaminophen 32.5 MG/ML
SCDC · 336021 -
Dextromethorphan hydrobromide 1 MG/ML
SCDC · 1020137 -
Acetaminophen / dextromethorphan Oral Solution
SCDF · 370756 -
Acetaminophen / dextromethorphan hydrobromide Oral Solution
SCDFP · 2647014 -
Acetaminophen / dextromethorphan Oral Liquid Product
SCDG · 1151183 -
Acetaminophen / dextromethorphan Oral Product
SCDG · 1151184 -
Acetaminophen / dextromethorphan hydrobromide Oral Liquid Product
SCDGP · 2661513 -
Acetaminophen / dextromethorphan hydrobromide Oral Product
SCDGP · 2662804
📦 FDA Products & Package NDCs
11 products · 13 package NDCs
13 package NDCs map to RxCUI 1919076 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00031-8750-12 | 1 BOTTLE in 1 CARTON (0031-8750-12) / 118 mL in 1 BOTTLE | Robitussin Maximum Strength Severe Cough Plus Sore Throat | Haleon US Holdings LLC | 2017-04-10 |
| 00031-8750-18 | 1 BOTTLE in 1 CARTON (0031-8750-18) / 237 mL in 1 BOTTLE | Robitussin Maximum Strength Severe Cough Plus Sore Throat | Haleon US Holdings LLC | 2017-04-10 |
| 00031-8771-12 | 1 BOTTLE in 1 CARTON (0031-8771-12) / 118 mL in 1 BOTTLE | Robitussin Honey Severe Cough, Flu Plus Sore Throat | Haleon US Holdings LLC | 2020-06-15 |
| 00031-8771-18 | 1 BOTTLE in 1 CARTON (0031-8771-18) / 237 mL in 1 BOTTLE | Robitussin Honey Severe Cough, Flu Plus Sore Throat | Haleon US Holdings LLC | 2020-06-15 |
| 51316-0631-08 | 1 BOTTLE in 1 CARTON (51316-631-08) / 237 mL in 1 BOTTLE | CVS Severe Cough, Flu Plus Sore Throat Honey | CVS PHARMACY | 2023-02-17 |
| 51316-0662-03 | 180 mL in 1 BOTTLE (51316-662-03) | Cough and Sore Throat | CVS | 2025-05-23 |
| 63824-0221-66 | 180 mL in 1 BOTTLE (63824-221-66) | Delsym Cough Plus Sore Throat | Reckitt Benckiser LLC | 2019-07-01 |
| 68163-0749-08 | 1 BOTTLE in 1 CARTON (68163-749-08) / 237 mL in 1 BOTTLE | DRx Choice maximum strength Severe Cough plus sore throat | RARITAN PHARMACEUTICALS | 2023-04-24 |
| 69842-0947-08 | 1 BOTTLE in 1 CARTON (69842-947-08) / 237 mL in 1 BOTTLE | CVS Severe Tussin CF Max | CVS PHARMACY | 2019-04-15 |
| 72854-0062-04 | 2 BOTTLE in 1 CARTON (72854-062-04) / 1 KIT in 1 BOTTLE *... | Mucinex Childrens | Reckitt Benckiser LLC | 2026-06-01 |
| 72854-0064-04 | 1 BOTTLE in 1 CARTON (72854-064-04) / 118 mL in 1 BOTTLE | Mucinex Childrens Fever Sore Throat and Cough | Reckitt Benckiser LLC | 2024-05-01 |
| 72854-0070-04 | 1 BOTTLE in 1 CARTON (72854-070-04) / 118 mL in 1 BOTTLE | Mucinex Childrens Multi-Symptom Cold and Flu | Reckitt Benckiser LLC | 2026-06-01 |
| 87078-0331-16 | 16 POUCH in 1 CARTON (87078-331-16) / 10 mL in 1 POUCH (870... | ONESSIP DAY TIME KIDS COLD AND COUGH PLUS FEVER | MEDWISE LIFESCIENCES INC. | 2026-05-15 |
Observed labelers:
Haleon US Holdings LLC (4) ·
Reckitt Benckiser LLC (4) ·
CVS PHARMACY (2) ·
CVS (1) ·
MEDWISE LIFESCIENCES INC. (1) ·
RARITAN PHARMACEUTICALS (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.